The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase III trial of systemic therapy plus early local therapy versus systemic therapy alone in women with de novo stage IV breast cancer: A trial of the ECOG-ACRIN Research Group (E2108).
 
Seema Ahsan Khan
No Relationships to Disclose
 
Fengmin Zhao
No Relationships to Disclose
 
Lawrence J. Solin
Consulting or Advisory Role - Genomic Health
Speakers' Bureau - Genomic Health
Other Relationship - Genomic Health
 
Lori J. Goldstein
Honoraria - Daiichi Sankyo; Genomic Health; Roche/Genentech; Teva
Consulting or Advisory Role - Aduro Biotech; Amgen; Eisai; Genentech; Genomic Health; Immunomedics; Merck; Mylan; Myriad Genetics; NanoString Technologies; Puma Biotechnology; Syndax
Research Funding - Genentech/Roche (Inst); Merck (Inst)
Other Relationship - Daiichi Sankyo
 
David Cella
Stock and Other Ownership Interests - FACIT.org
Consulting or Advisory Role - Abbvie; Actinium Pharmaceuticals; Asahi Kasei; Astellas Pharma; Bristol-Myers Squibb; Corcept Therapeutics; GlaxoSmithKline; IDDI; Ipsen; Ipsen; Novartis; Pfizer; PledPharma
Research Funding - Abbvie (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Ipsen (Inst); Novartis (Inst); Pfizer (Inst); PledPharma (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Ipsen; PledPharma
 
Mark Basik
Honoraria - Prosigna
Consulting or Advisory Role - Novartis
Research Funding - Sequenom
Travel, Accommodations, Expenses - Allergan
 
Mehra Golshan
Consulting or Advisory Role - Abbvie
Research Funding - Breast Cancer Research Foundation
 
Thomas B. Julian
No Relationships to Disclose
 
Barbara A. Pockaj
No Relationships to Disclose
 
Christine A Lee
No Relationships to Disclose
 
Wajeeha Razaq
No Relationships to Disclose
 
Joseph A. Sparano
Stock and Other Ownership Interests - Metastat
Consulting or Advisory Role - Adgero Biopharmaceuticals; AstraZeneca; Cardinal Health; Celgene; Celldex; Genentech/Roche; Juno Therapeutics; Lilly; Merrimack; Novartis; Pfizer; Prescient Therapeutics
Research Funding - Deciphera (Inst); Genentech/Roche (Inst); Merck (Inst); Merrimack (Inst); Novartis (Inst); Novartis (Inst); Prescient Therapeutics (Inst); Radius Health (Inst)
Travel, Accommodations, Expenses - Adgero Biopharmaceuticals; AstraZeneca; Menarini Silicon Biosystems; Myriad Genetics; Pfizer; Roche/Genentech
 
Gildy V Babiera
No Relationships to Disclose
 
Irene Ang Dy
No Relationships to Disclose
 
Sarika Jain
No Relationships to Disclose
 
Paula Silverman
No Relationships to Disclose
 
Carla Fisher
No Relationships to Disclose
 
Amye Juliet Tevaarwerk
Other Relationship - Epic Systems (I)
 
Lynne I. Wagner
Consulting or Advisory Role - Celgene
Travel, Accommodations, Expenses - Celgene
 
George W. Sledge
Leadership - Syndax; Tessa Therapeutics
Stock and Other Ownership Interests - Syndax; Tessa Therapeutics
Consulting or Advisory Role - Radius Health; Symphogen; Synaffix; Syndax; Taiho Pharmaceutical; Verseau Therapeutics
Research Funding - Genentech/Roche (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Radius Health; Tessa Therapeutics; Verseau Therapeutics